| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/14/2009 | CN101342368A Antigenized antibody vaccine for foot-and-mouth disease |
| 01/14/2009 | CN101341886A Enhancement of growth in plants |
| 01/14/2009 | CN100451127C Peptides with anti-hypertensive properties |
| 01/14/2009 | CN100451123C Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 01/14/2009 | CN100451122C Rape transgenic method |
| 01/14/2009 | CN100451121C Gene for controlling rice ear sprouting period and its uses |
| 01/14/2009 | CN100451120C Molecular breeding method of ternary cotton hybrid with insect-resisting transgene |
| 01/14/2009 | CN100451119C Method for preparing gene serial number of lysozyme of tussah, and expression production |
| 01/14/2009 | CN100451118C Paddy lignin synthesis gene FC1 and uses |
| 01/14/2009 | CN100451117C Dehiscence gene and methods for regulating dehiscence |
| 01/14/2009 | CN100451116C Human tissue factor pathway inhibitory factor mutation gene mTFPI, recombination carrier including the same and host cell thereof |
| 01/14/2009 | CN100451115C Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain |
| 01/14/2009 | CN100451114C Infuse protein of candida albicans hot shock protein 90 epitope and phage envelop protein , and its uses |
| 01/14/2009 | CN100451113C Gene transfer method for promoting insect resistance of soybean |
| 01/14/2009 | CN100451109C Recombinant herpes simplex virus type 2 and its preparing method and use |
| 01/14/2009 | CN100451108C L-lysine-producing corynebacteria and process for the preparation of L-lysine |
| 01/14/2009 | CN100451104C L-lysine producing coryneform bacteria and methods for the production of L-lysine |
| 01/14/2009 | CN100451102C Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
| 01/14/2009 | CN100451097C Aspergillus niger |
| 01/14/2009 | CN100451034C Pig gamma interferon and encoding genes and use thereof |
| 01/14/2009 | CN100451033C Gene for inhibiting human transcription factor AP-1, its encoding polypeptide and uses |
| 01/14/2009 | CN100450552C Vaccine for diabetes in type I, and constructing method |
| 01/14/2009 | CN100450551C Recombinated adeno-associated virus genes vaccine for prevention and cure of Alzheimer disease and use thereof |
| 01/13/2009 | US7476785 Plants and seeds of corn variety I136815 |
| 01/13/2009 | US7476784 Plants and seeds of corn variety I079171 |
| 01/13/2009 | US7476783 Plants and seeds of corn variety I210292 |
| 01/13/2009 | US7476781 Bacillus thuringiensis cry gene and protein |
| 01/13/2009 | US7476780 Root agroinoculation method for virus induced gene silencing |
| 01/13/2009 | US7476779 Generation of plants with altered oil content |
| 01/13/2009 | US7476778 Expression vector comprising nucleotide sequences coding raffinose saccharide biosynthetic enzyme for use in propagation of soybean with reduced raffinose saccharide concentration |
| 01/13/2009 | US7476777 apomictic plant containing a transgene for a desired trait and a transgene causing seed infertility; Seeds that are formed on such plants are infertile |
| 01/13/2009 | US7476776 isolating primordial germ cells from avian embryonic gonad; and culturing in vitro for 10 days on a gonadal stroma feeder cell layer until positive for stage specific embryonic antigen-1; injecting into dorsal aorta of recipient chicken embryo without prior treatment; incubating and hatching egg |
| 01/13/2009 | US7476732 Nucleic acid encoding α chain of human IL-11 receptor |
| 01/13/2009 | US7476731 Variants of the alpha 1 subunit of human AMPK |
| 01/13/2009 | US7476730 Encoding glycosaminoglycan 6-O-sulfotransferase for use in diagnosis of tumor disorders |
| 01/13/2009 | US7476729 Dbait and uses thereof |
| 01/13/2009 | US7476728 Flea GABA receptor subunit nucleic acid molecules |
| 01/13/2009 | US7476726 employed for large scale recovery and purification; centrifugation of the broth from fermentation steps in recombinant production of endostatin protein is avoided, thereby preventing unwanted potential cellular lysis and potential contamination |
| 01/13/2009 | US7476722 Chromatography separation using apatite; protein being purified can comprise at least one constant antibody immunoglobulin domain |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476720 Rat neurotrophic factor receptor, GFR α-4 |
| 01/13/2009 | US7476719 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
| 01/13/2009 | US7476709 Solid phase synthesis using a solid support prepared by polymerization of a polyarylmethyl-protected alkoxylated styrene monomer that has 2-10 oxyalkylene units |
| 01/13/2009 | US7476539 DNA containing variant FRT sequences |
| 01/13/2009 | US7476536 Artificial human chromosome containing human antibody a light chain gene |
| 01/13/2009 | US7476535 Tyrosinase-related gene (TRP2) protein comprising human leukocyte antigen cytotoxic binding recognition points for identifying modulators for diagnosis, prevention and treatment of cancer ; immunotherapy |
| 01/13/2009 | US7476532 Mannitol induced promoter systems in bacterial host cells |
| 01/13/2009 | US7476531 productivity of the bacterium is enhanced by enhancing an activity of proteins coded by b2682 and b2683 genes, or protein coded by b1242 or b3434 gene |
| 01/13/2009 | US7476528 Proteins producing an altered immunogenic response and methods of making and using the same |
| 01/13/2009 | US7476527 Comprises nucleotide sequences coding galactosyltransferase for use in treatment or prevention of aberrant cell surface glycosylation associated with tumor progression |
| 01/13/2009 | US7476526 Protein for use in generating resistance to bactericides in cells |
| 01/13/2009 | US7476525 Modified pyrroloquinoline quinone (PQQ) dependent glucose dehydrogenase with superior substrate specificity and stability |
| 01/13/2009 | US7476524 Comprises nucleotide sequences coding prostaglandin h synthase for treatment of inflammation; antiinflammatory agents; cytoprotective agents |
| 01/13/2009 | US7476521 acyl group of acyl coenzyme A is transferred to an acyl group receptor characterized in that the reaction is carried out by production and/or reproduction of acyl coenzyme A from coenzyme A in a reaction system by a chemical thioester exchange reaction with acylthioester |
| 01/13/2009 | US7476518 Nucleic acids encoding fluorescent proteins and methods of using the same |
| 01/13/2009 | US7476517 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 01/13/2009 | US7476508 bringing a test substance into contact with a screening tool, wherein said screening tool exhibits calcium ion-permeable ion channel activity upon activation with the pregnenolone sulfate |
| 01/13/2009 | US7476496 Method for preparing an extracellular matrix and its use for tumor cell culture |
| 01/13/2009 | US7476401 Noncovalent interaction of a charged polypeptide with a surfactant of opposite charge to form a polypeptide-surfactant mixture; lyophilizing to form a dried salt complex; for delivering a polypeptide |
| 01/13/2009 | US7476391 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/13/2009 | US7476390 Polypeptides and polynucleotides useful in methods of inducing immune response against flaviviruses, including dengue viruses |
| 01/13/2009 | US7476389 Papillomavirus vaccines |
| 01/13/2009 | US7476384 Death domain containing receptor 4 antibody and methods |
| 01/13/2009 | US7476382 Reovirus for the treatment of neoplasia |
| 01/13/2009 | CA2615372A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/13/2009 | CA2446982C Synthesis and evaluation of new cyanine dyes as minor groove of [poly(da-dt)]2 binders |
| 01/13/2009 | CA2408972C Genes encoding plant transcription factors |
| 01/13/2009 | CA2374729C Novel organic anion transport proteins |
| 01/13/2009 | CA2296044C Oligonucleotide primers for efficient multiplex detection of hepatitis c virus (hcv) and human immunodeficiency virus (hiv) and methods of use thereof |
| 01/13/2009 | CA2287524C Dna probes, method and kit for identifying antibiotic-resistant strains of bacteria |
| 01/13/2009 | CA2273078C Use of nucleic acids bound to carrier macromolecules |
| 01/13/2009 | CA2263750C Use of a melanoma differentiation associated gene (mda-7) for reversing a cancerous phenotype |
| 01/13/2009 | CA2233932C Vaccines against infections caused by yf virus; yf infectious cdna, method for producing a recombinant yf virus from the yf infectious cdna and plasmids to assemble the yf infectious cdna |
| 01/13/2009 | CA2105534C Tnf ligands |
| 01/08/2009 | WO2009006638A2 Peptides facilitating retrograde transport and their uses |
| 01/08/2009 | WO2009006618A2 Herpes simplex virus mutant icp0 protein |
| 01/08/2009 | WO2009006584A2 Methods and compositions for identifying cellular rna transcripts |
| 01/08/2009 | WO2009006460A1 Rnai-mediated inhibition of htra1 for treatment of macular degeneration |
| 01/08/2009 | WO2009006438A2 Copy dna and sense rna |
| 01/08/2009 | WO2009006300A2 Production cell lines for adenoviral manufacturing |
| 01/08/2009 | WO2009006297A2 Methods for altering the genome of a monocot plant cell |
| 01/08/2009 | WO2009006281A1 Plasmid-encoded neurotoxin genes in clostridium botulinum serotype a subtypes |
| 01/08/2009 | WO2009006276A1 Plants with altered root architecture, involving the rt1 gene, related constructs and methods |
| 01/08/2009 | WO2009005813A1 Modulators of axl for use in treating bone disorders |
| 01/08/2009 | WO2009005564A2 Cellulose- and hemicellulose-degradation enzyme -encoding nucleotide sequences with refined translational kinetics and methods of making same |
| 01/08/2009 | WO2009005178A1 Microarrays for detection and identification of microorganisms associated with periodontal diseases and method for diagnosis of infectious oral diseases using the microarray |
| 01/08/2009 | WO2009005155A1 Method for maintaining proliferation/differentiation ability of mesenchymal stem cell |
| 01/08/2009 | WO2009005142A1 Method for diagnosis of malignancy of gastrointestinal stromal tumor whose primary lesion is in stomach |
| 01/08/2009 | WO2009005140A1 C-terminal-α-amidated recombinant enzyme derivative |
| 01/08/2009 | WO2009005124A1 Double-stranded rna originating in lactic acid bacterium |
| 01/08/2009 | WO2009005095A1 Treatment of influenza |
| 01/08/2009 | WO2009005040A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 01/08/2009 | WO2009005001A1 Apparatus for detecting/identifying gene, apparatus for gene reaction and incubator |
| 01/08/2009 | WO2009004967A1 Endoglycoceramidase i gene |
| 01/08/2009 | WO2009004922A1 Lactic acid production method |
| 01/08/2009 | WO2009004842A1 Vaccine for swine edema disease |
| 01/08/2009 | WO2009004822A1 ANTI-Muc17 ANTIBODY |
| 01/08/2009 | WO2009004632A2 Methods of identifying components of a biological pathway and use of said components in regulating diseases associated with altered cell proliferation |
| 01/08/2009 | WO2009004575A2 Cartilage-specific expression |
| 01/08/2009 | WO2009004484A2 Trim24 (tifla) as p53 modulator and cancer target |